Viscoat syringe 0.75ML
Ended Awarded Last action
- Contract number
- SPE2DR26F9KZ1
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $17,145
Award facts
- Contract value 100% obligated
- $17,145.49 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
This delivery order, valued at $17,145.49, was awarded on January 13, 2026, to AmerisourceBergen Drug Corp (UEI: KABZK8W6PQT3), a subsidiary of Cencora, Inc., for the supply of Viscoat syringes (0.75mL). The award was funded by the Defense Logistics Agency (DLA) under the Defense Logistics Agency's supply chain operations and carries a firm fixed-price structure with no set-aside designation, indicating competitive award. The place of performance is located in Conshohocken, Pennsylvania, with an ultimate completion date of January 14, 2026. This delivery order is issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated as SPE2DX, which is valued at up to $999,999,999.00 and extends through December 2026, serving as a comprehensive global pharmaceutical support vehicle.
AmerisourceBergen Drug Corp is a major pharmaceutical distributor and critical federal vendor specializing in supplying a comprehensive range of pharmaceutical products and medical supplies to military and veteran healthcare systems. The company's extensive federal contract portfolio demonstrates its capability to fulfill diverse medical procurement needs through the DLA Medical Supply Chain, supporting Defense Health Agency, U.S. Coast Guard, and other government healthcare systems with medications, vaccines, syringes, and specialized medical commodities across multiple therapeutic domains. As the child entity of parent company Cencora, Inc., the awardee leverages its position within a large pharmaceutical distribution network to deliver essential medical supplies efficiently to federal government agencies.
Quick answers
Who was awarded contract SPE2DR26F9KZ1?
SPE2DR26F9KZ1 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 13, 2026.
How much is contract SPE2DR26F9KZ1 worth?
The government has obligated $17,145 on SPE2DR26F9KZ1.
Is contract SPE2DR26F9KZ1 an order under another contract?
Yes. SPE2DR26F9KZ1 is a delivery order under SPE2DR25D2206, an indefinite delivery contract.
Was contract SPE2DR26F9KZ1 competed?
The extent of competition for SPE2DR26F9KZ1 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award